Capricor Therapeutics, Inc.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2024 - Q4(Oct 24 · Nov 24 · Dec 24)
Total Assets
$356M
↑+108.8% +$185Mvs FY2024
Total Liabilities
$50M
↑+100.5% +$25Mvs FY2024
Equity
$306M
↑+110.2% +$160Mvs FY2024
Cash
$288M
↑+2450.3% +$277Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $356M | $170M |
| Current Assets | $323M | $163M |
| Cash | $288M | $11M |
| ST Investments | $0 | $140M |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current | $35M | $12M |
| Non-Current Assets | $33M | $7M |
| PPE | $18M | $6M |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $15M | $2M |
| Total Liab+Eq | $356M | $170M |
| Current Liab. | $36M | $21M |
| Accounts Payable | $2M | $3M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $12M | $12M |
| Other CL | $22M | $6M |
| Non-Current Liab. | $14M | $4M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $14M | $4M |
| Equity | $306M | $145M |
| Retained Earnings | $305M | $200M |
| Other Equity | $914K | $0 |
QuarterCharts · SEC EDGAR data · CAPR · Comparing FY2025 vs FY2024